ORIC Pharmaceuticals Inc ORIC

NAS: ORIC | ISIN: US68622P1093 30/04/2025

5,710 USD (+0,97%)

(+0,97%) 30/04/2025

Grafiek ORIC Pharmaceuticals Inc

Grafiek ORIC Pharmaceuticals Inc

1 dag1d 0,97%
1 week1w 10,02%
1 maand1m 3,25%
3 maanden3m -43,74%
6 maanden6m -39,32%
1 jaar1j -38,80%
5 jaar5j -78,49%

ORIC Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

10 maart 2021 · ORIC Pharmaceuticals to Present Posters on Four Programs at the 2021 American Association for Cancer Research (AACR) Annual Meeting · Persbericht

2 maart 2021 · ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences · Persbericht

3 februari 2021 · ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences · Persbericht

11 januari 2021 · ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones · Persbericht

4 januari 2021 · ORIC Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel ORIC Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: oricpharma.com

Hoofdzetel: South San Francisco, California Verenigde Staten

CEO: Jacob Chacko

Werknemers: 86

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe